| A "Silent" Polymorphism in the MDR1 Gene Changes Substrate Specificity C Kimchi-Sarfaty, JM Oh, IW Kim, ZE Sauna, AM Calcagno, SV Ambudkar, ... Science 315 (5811), 525-528, 2007 | 3022 | 2007 |
| Pharmacokinetics of drugs in rats with diabetes mellitus induced by alloxan or streptozocin: comparison with those in patients with type I diabetes mellitus JH Lee, SH Yang, JM Oh, MG Lee Journal of Pharmacy and Pharmacology 62 (1), 1-23, 2010 | 140 | 2010 |
| Low‐dose botulinum toxin type A for the treatment of refractory piriformis syndrome SJ Yoon, J Ho, HY Kang, SH Lee, KI Kim, WG Shin, JM Oh Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 27 (5 …, 2007 | 92 | 2007 |
| Prediction of the tacrolimus population pharmacokinetic parameters according to CYP3A5 genotype and clinical factors using NONMEM in adult kidney transplant recipients N Han, H Yun, J Hong, IW Kim, E Ji, SH Hong, YS Kim, J Ha, WG Shin, ... European journal of clinical pharmacology 69 (1), 53-63, 2013 | 87 | 2013 |
| Protective Effects of Haematococcus Astaxanthin on Oxidative Stress in Healthy Smokers JH Kim, MJ Chang, HD Choi, YK Youn, JT Kim, JM Oh, WG Shin Journal of medicinal food 14 (11), 1469-1475, 2011 | 78 | 2011 |
| CYP3A5* 1 allele: impacts on early acute rejection and graft function in tacrolimus-based renal transplant recipients SI Min, SY Kim, SH Ahn, SK Min, SH Kim, YS Kim, KC Moon, JM Oh, ... Transplantation 90 (12), 1394-1400, 2010 | 78 | 2010 |
| Combinational effect of intestinal and hepatic CYP3A5 genotypes on tacrolimus pharmacokinetics in recipients of living donor liver transplantation E Ji, L Choi, KS Suh, JY Cho, N Han, JM Oh Transplantation 94 (8), 866, 2012 | 65 | 2012 |
| Epigenetic changes in gene expression for drug‐metabolizing enzymes and transporters IW Kim, N Han, GJ Burckart, JM Oh Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34 (2 …, 2014 | 61 | 2014 |
| Population pharmacokinetic–pharmacogenetic model of tacrolimus in the early period after kidney transplantation N Han, S Ha, H Yun, MG Kim, SI Min, J Ha, JI Lee, JM Oh, IW Kim Basic & clinical pharmacology & toxicology 114 (5), 400-406, 2014 | 60 | 2014 |
| Pharmacokinetic study of mycophenolic acid in Korean kidney transplant patients EK Cho, DJ Han, SC Kim, GJ Burckart, R Venkataramanan, JM Oh The Journal of Clinical Pharmacology 44 (7), 743-750, 2004 | 57 | 2004 |
| Factors affecting the apparent clearance of tacrolimus in Korean adult liver transplant recipients JY Lee, HJ Hahn, IJ Son, KS Suh, NJ Yi, JM Oh, WG Shin Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 26 (8 …, 2006 | 54 | 2006 |
| Transdermal delivery of low molecular weight heparin loaded in flexible liposomes with bioavailability enhancement: comparison with ethosomes YK Song, SY Hyun, HT Kim, CK Kim, JM Oh Journal of microencapsulation 28 (3), 151-158, 2011 | 52 | 2011 |
| Clinical and genetic factors affecting tacrolimus trough levels and drug-related outcomes in Korean kidney transplant recipients IW Kim, YJ Moon, E Ji, KI Kim, N Han, SJ Kim, WG Shin, J Ha, JH Yoon, ... European journal of clinical pharmacology 68 (5), 657-669, 2012 | 50 | 2012 |
| Gene–gene interaction analysis for the survival phenotype based on the Cox model S Lee, MS Kwon, JM Oh, T Park Bioinformatics 28 (18), i582-i588, 2012 | 46 | 2012 |
| Current globalization of drug interventional clinical trials: characteristics and associated factors, 2011–2013 S Jeong, M Sohn, JH Kim, M Ko, H Seo, YK Song, B Choi, N Han, HS Na, ... Trials 18 (1), 1-8, 2017 | 43 | 2017 |
| Pharmacist‐involved care for patients with heart failure and acute coronary syndrome: a systematic review with qualitative and quantitative meta‐analysis JE Kang, NY Han, JM Oh, HK Jin, HA Kim, IJ Son, SJ Rhie Journal of clinical pharmacy and therapeutics 41 (2), 145-157, 2016 | 40 | 2016 |
| Identification of factors affecting tacrolimus level and 5‐Year clinical outcome in kidney transplant patients IW Kim, H Noh, E Ji, N Han, SH Hong, J Ha, GJ Burckart, JM Oh Basic & clinical pharmacology & toxicology 111 (4), 217-223, 2012 | 40 | 2012 |
| Increased exposure of tacrolimus by co-administered mycophenolate mofetil: population pharmacokinetic analysis in healthy volunteers JH Kim, N Han, MG Kim, HY Yun, S Lee, E Bae, YS Kim, IW Kim, JM Oh Scientific reports 8 (1), 1-9, 2018 | 36 | 2018 |
| Population pharmacokinetics and pharmacodynamics of busulfan with GSTA1 polymorphisms in patients undergoing allogeneic hematopoietic stem cell … B Choi, MG Kim, N Han, T Kim, E Ji, S Park, IW Kim, JM Oh Pharmacogenomics 16 (14), 1585-1594, 2015 | 36 | 2015 |
| Recombinant human epidermal growth factor on oral mucositis induced by intensive chemotherapy with stem cell transplantation KI Kim, JW Kim, HJ Lee, BS Kim, SM Bang, I Kim, JM Oh, SS Yoon, ... American Journal of Hematology 88 (2), 107-112, 2013 | 36 | 2013 |
